As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease. Alzforum, 07 Jul 2023 Guan PP, Ge TQ, Wang P. J Neuroimmune Pharmacol. 2023 Jun 29; PubMed.